首页 | 本学科首页   官方微博 | 高级检索  
检索        

腺病毒介导microRNA-99a过表达抑制肝癌细胞生长
引用本文:张敬磊,金华君,刘辉,吕赛群,杨远,傅思源,钱其军,周伟平.腺病毒介导microRNA-99a过表达抑制肝癌细胞生长[J].中国肿瘤生物治疗杂志,2012,19(3):267-271.
作者姓名:张敬磊  金华君  刘辉  吕赛群  杨远  傅思源  钱其军  周伟平
作者单位:第二军医大学 东方肝胆外科医院 肝外三科,上海 200438;第二军医大学 东方肝胆外科医院 基因与病毒治疗实验室,上海 200438;第二军医大学 东方肝胆外科医院 肝外三科,上海 200438;第二军医大学 东方肝胆外科医院 基因与病毒治疗实验室,上海 200438;第二军医大学 东方肝胆外科医院 肝外三科,上海 200438;第二军医大学 东方肝胆外科医院 肝外三科,上海 200438;第二军医大学 东方肝胆外科医院 基因与病毒治疗实验室,上海 200438;第二军医大学 东方肝胆外科医院 肝外三科,上海 200438
基金项目:国家重大传染病防治科技专项基金资助项目(No. 2008ZX10002-018)
摘    要:目的:利用腺病毒介导microrRNA-99a(miR-99a)的过表达,观察miR-99a对肝癌细胞生长的抑制作用,探讨一种腺病毒介导miRNA治疗肿瘤的新方法。方法:qRT-PCR检测正常肝细胞系L-02和肝癌细胞系HepG2、SMMC-7721、Hep3B和Huh7细胞中miR-99a的表达,构建含miR-99a的重组5型腺病毒Ad5-miR-99a。用空载腺病毒Ad-blank和Ad5-miR-99a分别感染Huh7细胞,MTT法和集落形成实验检测miR-99a过表达对Huh7细胞生长的抑制作用。结果:与正常肝细胞L02和其他肝癌细胞相比,miR-99a在肝癌Huh7细胞中表达量相对最低(P<0.01)。成功构建重组腺病毒Ad5-miR-99a,Ad5-miR-99a感染Huh7细胞后,miR-99a可在Huh7细胞中稳定高表达。集落形成实验和MTT实验显示,相对于Ad-blank组,Ad5-miR-99a可显著抑制Huh7细胞的生长和集落形成(P<0.01)。结论:成功构建重组腺病毒Ad5-miR-99a,miR-99a能有效抑制肝癌细胞的增殖,Ad5-miR-99a有可能成为治疗肝癌的新药物。

关 键 词:miRNA-99a  5型腺病毒  肝细胞癌  靶向基因治疗
收稿时间:2012/2/23 0:00:00
修稿时间:2012/4/13 0:00:00

Adenovirus mediated overexpression of miR-99a inhibits the growth of hepato-cellular carcinoma cells
ZHANG Jing-lei,JIN Hua-jun,LIU Hui,L Sai-qun,YANG Yuan,FU Si-yuan,QIAN Qi-jun and ZHOU Wei-ping.Adenovirus mediated overexpression of miR-99a inhibits the growth of hepato-cellular carcinoma cells[J].Chinese Journal of Cancer Biotherapy,2012,19(3):267-271.
Authors:ZHANG Jing-lei  JIN Hua-jun  LIU Hui  L Sai-qun  YANG Yuan  FU Si-yuan  QIAN Qi-jun and ZHOU Wei-ping
Institution:Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;Laboratory of Virus Gene Therapy, Eastern Hepatobiliary Surgical Hospital, Second Military Medical University, Shanghai 200438, China;Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;Laboratory of Virus Gene Therapy, Eastern Hepatobiliary Surgical Hospital, Second Military Medical University, Shanghai 200438, China;Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China;Laboratory of Virus Gene Therapy, Eastern Hepatobiliary Surgical Hospital, Second Military Medical University, Shanghai 200438, China;Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China
Abstract:Objective: To study the inhibitory effect of adenovirus-mediated-miR-99a overexpression on proliferation of hepatocellular carcinoma cells(HCCs) and find a new kind of adenovirus mediated miRNA treatment for cancer.Methods: The expression of miR-99a was detected by quantitative real-time polymerase chain reaction(qRT-PCR) in human liver cell line L-02 and HCC cell lines HepG2,SMMC-7721,Hep3B and Huh7.The type 5 adenovirus vector containing miR-99(Ad5-miR-99a) was constructed.Huh7 cells were infected with empty adenovirus vector(Ad-blank) or Ad5miR-99a,and MTT and colony formation assay were used to examine the inhibitory effect of miR-99a on the growth of Huh7 cells.Results: miRNA-99a was markedly decreased in the Huh7 cell line compared with that in L02 cell line(P < 0.01).Ad5-miR-99a adenovirus vector was successfully constructed,and miR-99a was stably high expressed in Huh7 cells after infection with Ad5-miR-99a.MTT and colony formation assay showed that Ad5-miR-99a could inhibit the growth and colony formation of Huh7 cells compared with Ad-blank(P < 0.01).Conclusion: Adenovirus Ad5-miR-99a is successfully constructed,which can effectively suppress the growth of HCC.Ad5-miR-99a might be a prospective therapeutic approach for HCC in the near future.
Keywords:miRNA-99a  Type 5 adenovirus  hepatocellular carcinoma  target gene therapy
本文献已被 CNKI 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号